HC Wainwright reiterated their buy rating on shares of Lyra Therapeutics (NASDAQ:LYRA – Free Report) in a research report report published on Wednesday, Benzinga reports. HC Wainwright currently has a $12.00 price target on the stock. A number of other research analysts have also commented on LYRA. Bank of America lowered their price target on […]
Lyra Therapeutics (NASDAQ:LYRA – Free Report) had its price target trimmed by Bank of America from $12.00 to $11.00 in a research report released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. LYRA has been the subject of several other reports. HC Wainwright reiterated a buy rating and issued […]
Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 421,100 shares, a growth of 661.5% from the August 31st total of 55,300 shares. Based on an average trading volume of 348,200 shares, the days-to-cover ratio […]
HC Wainwright assumed coverage on shares of Lyra Therapeutics (NASDAQ:LYRA – Free Report) in a research report released on Thursday, MarketBeat reports. The brokerage issued a buy rating and a $12.00 price target on the stock. Lyra Therapeutics Stock Up 0.3 % Shares of LYRA stock opened at $3.49 on Thursday. The business has a […]